Anteris Technologies Global Corp.
NASDAQ:AVRMedical - Devices
-$0.02 today
- Market cap
- $507.94M
- Beta
- 0.73
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$4.04
Volume 1.24M
Average 1.18M
AVR Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Anteris Technologies Global Corp.NASDAQ: AVR
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns positive
Q1 FY2026 other income / expenses was $1.6M, compared with -$151K a year earlier. Trailing-twelve-month other income / expenses was $1.42M.
Context
- Other income / expenses amounted to 17.3% of revenue in FY2025, down 71.7 pp from a year earlier.
- Other income / expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near $1.6M or moves back toward the trailing-twelve-month quarterly average of $355.25K.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (331K) USD
- Year-over-year change
- -113.8%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (331K) | -113.8% |
| FY2024 | 2024-12-31 | 2.41M | +74.7% |
| FY2023 | 2023-12-31 | 1.38M | +150.1% |
| FY2022 | 2022-12-31 | 550.48K | +277.3% |
| FY2021 | 2021-12-31 | (310.48K) | — |
Other Income / Expenses vs competitors
How AVR compares with its peers on the latest reported figures
- AVR's LTM Mar 2026 other income / expenses of $1.42M is the highest of the 6 companies compared; the peer median is -$183M.
- Its year-over-year change of -23.4% is the 4th highest of 6, against a peer median of +52.5%.
- Other income / expenses amounts to 76.8% of revenue for AVR, versus a peer median of 3.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $1.42M | -23.4% | — | 76.8% |
| LTM Mar 2026 | -$18.17M | +52.5% | — | 4.0% | |
| LTM Sep 2026 | -$53.12M | +86.2% | — | 3.5% | |
| LTM Jul 2026 | -$183M | +60.2% | — | 0.5% | |
| LTM Jun 2026 | -$412M | -398.3% | — | 6.3% | |
| LTM Jun 2026 | -$645M | -3171.4% | — | 3.1% | |
| Peer median (excluding AVR) | -$183M | +52.5% | — | 3.5% | |
Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.83M | 3.2M | 2.73M | 2.7M | 1.91M |
| Cost of Revenue | 3.93M | 2.9M | 1.86M | 1.44M | 2.23M |
| Gross Profit | 1.91M | 298.38K | 876.8K | 1.27M | (317K) |
| Gross Margin | 32.7% | 9.3% | 32.1% | 46.8% | -16.6% |
| Research & Development | 9.99M | 17.59M | 31.02M | 51.45M | 69.12M |
| Selling, General & Admin | 9.14M | 15.21M | 17.05M | 0 | 24.46M |
| Operating Expenses | 18.77M | 31.41M | 49.02M | 79.64M | 93.58M |
| Depreciation & Amortization | 640.09K | 774.08K | 1.16M | 1.51M | 1.66M |
| EBITDA | (15.5M) | (29.14M) | (45.54M) | (74.38M) | (92.49M) |
| EBITDA Margin | -265.8% | -910.5% | -1665.1% | -2751.7% | -4834.9% |
| Operating Income | (16.86M) | (31.11M) | (48.14M) | (78.37M) | (93.89M) |
| Operating Margin | -289.2% | -972.1% | -1760.3% | -2899.4% | -4908.2% |
| Interest Income | 68.55K | 210.38K | 428.06K | 0 | 709K |
| Interest Expense | 1.03M | 648.71K | 67.09K | 82K | 73K |
| Other Income / Expenses | (310.48K) | 550.48K | 1.38M | 2.41M | (331K) |
| Income Before Tax | (17.17M) | (30.56M) | (46.76M) | (75.97M) | (94.23M) |
| Pre-Tax Margin | -294.5% | -954.9% | -1709.9% | -2810.5% | -4925.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (17.17M) | (30.56M) | (46.02M) | (76.29M) | (94.14M) |
| Net Margin | -294.5% | -954.9% | -1682.8% | -2822.5% | -4921.3% |
| EPS (Basic) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| EPS (Diluted) | (0.48) | (0.85) | (1.28) | (3.77) | (4.00) |
| Weighted Avg Shares | 35.94M | 35.94M | 35.94M | 20.25M | 23.58M |
| Weighted Avg Shares (Diluted) | 35.94M | 35.94M | 35.94M | 20.25M | 23.58M |
Anteris Technologies Global Corp.
NASDAQ:AVR
Intrinsic Alpha fair value
Locked
Current Price
$5.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.